Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients
Condition: Hepatitis B Virus (HBV) Interventions: Biological: T101 Group; Biological: Placebo Group Sponsor: Tasly Tianjin Biopharmaceutical Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials